BioAtla
BCAB
BCAB
73 hedge funds and large institutions have $208M invested in BioAtla in 2022 Q3 according to their latest regulatory filings, with 21 funds opening new positions, 21 increasing their positions, 22 reducing their positions, and 26 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more capital invested
Capital invested by funds: $ → $
more ownership
Funds ownership: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
6% less funds holding
Funds holding: 78 → 73 (-5)
19% less first-time investments, than exits
New positions opened: 21 | Existing positions closed: 26
Holders
73
Holding in Top 10
1
Calls
$3.34M
Puts
$726K
Top Buyers
| 1 | +$15.5M | |
| 2 | +$11.8M | |
| 3 | +$6.12M | |
| 4 |
Point72 Asset Management
Stamford,
Connecticut
|
+$5.89M |
| 5 |
ACA
Avoro Capital Advisors
New York
|
+$4.43M |
Top Sellers
| 1 | -$10.8M | |
| 2 | -$2.94M | |
| 3 | -$2.35M | |
| 4 |
Fidelity Investments
Boston,
Massachusetts
|
-$2.27M |
| 5 |
Two Sigma Investments
New York
|
-$1.75M |